Free Miamind Device Trials
Bottneuro is offering Miamind devices for free testing, exclusively available to neurology clinics, memory clinics, and private practices.
Attention Neurologists, Psychiatrists, and Medical Professionals in Switzerland: Are you interested in cutting-edge treatment options? Through our Priority Access Program, we are offering free testing of our Miamind® devices. These devices employ our innovative, patient-specific, non-invasive, multifocal neurostimulation therapy, which is personalized based on clinical profiles and MRI data. Take this opportunity to explore advanced, personalized care solutions for your patients.
Benefits of our Miamind® Neurostimulators
Personalized
Each device is tailored to the patient’s specific MRI data. The therapy plan is created after prescription and target region definition by the expert.
Non-invasive
Transcranial stimulation (tCS) offers a safe, non-invasive alternative to treatments with reduced risks, according to current research.
Scientifically backed
The benefits of tCS are grounded in extensive research and clinical studies.
Personalized
Neurostimulation Solutions
Our innovative neurostimulation technology is designed to address a variety of medical conditions, offering
personalized, non-invasive solutions for improved patient outcomes.
Our Partner Clinics
Priority Access Program Partner
Dr. Filip Barinka
Altersneurologie am Swiss
Clinical Neuro Science Institute (SCNSI)
Bürglistrasse 29
8002 Zürich
Priority Access Program Partner
Bellevue Medical Group AG
Neurocenter Bellevue
Theaterstrasse 8
8001 Zürich
Priority Access Program Partner
Fachklinik KopfwehZentrum Hirslanden
Forchstrasse 424,
8702 Zollikon,
Switzerland